GSK hopes big clinical trial can breath new life into lung drug
* Results of SUMMIT trial with Breo due as early as Sept * Drug could be first to extend lives in COPD * Billions of dollars riding on positive outcome * U.S. partner Theravance eligible for royalties on sales By Ben Hirschler LONDON, Aug 13 (Reuters) - GlaxoSmithKli
Read more